Latest (54) Full Text Articles (1570) Focus on Pancreas Article Summary

Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: A phase IIb trial
Gastroenterology, 01/24/2014  Clinical Article

Zeuzem S, et al. – The authors performed a phase IIb, randomized, double–blind, placebo–controlled trial to evaluate the efficacy and safety of the combination of simeprevir, peginterferon–α2a (PegIFN), and ribavirin (RBV) in patients with hepatitis C virus (HCV) genotype–1 infection previously treated with PegIFN and RBV. In treatment–experienced patients, 12, 24, or 48 weeks simeprevir (100 mg or 150 mg once daily) in combination with 48 weeks PegIFN and RBV significantly increased rates of SVR at 24 weeks compared with patients given placebo, PegIFN, and RBV and was generally well tolerated.


  • The authors analyzed data from patients who did not respond (null response), had a partial response, or relapsed after treatment with PegIFN and RBV, randomly assigned to receive simeprevir (100 or 150 mg, once daily) for 12, 24, or 48 weeks plus PegIFN and RBV for 48 weeks (n = 396), or placebo plus PegIFN and RBV for 48 weeks (n = 66).
  • All patients were followed for 24 weeks after planned end of treatment; the primary end point was the proportion of patients with sustained virologic response (SVR; undetectable HCV RNA) at that time point.


  • Overall, rates of SVR at 24 weeks were significantly higher in the groups given simeprevir than those given placebo (61%-80% vs 23%; P < .001), regardless of prior response to PegIFN and RBV (simeprevir vs placebo: prior null response, 38%-59% vs 19%; prior partial response, 48%-86% vs 9%; prior relapse, 77%-89% vs 37%).
  • All groups had comparable numbers of adverse events; these led to discontinuation of simeprevir or placebo and/or PegIFN and RBV in 8.8% of patients given simeprevir and 4.5% of those given placebo.

► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Gastroenterology

See All >> Messages include industry-sponsored communications and special communications from PDR - powered by MDLinx

Most Popular Gastroenterology Articles

Last month's top read Top Articles of 2014

1 American Medical Group Association's 2015 Medical Group Compensation and Productivity Survey reports average increase in physician compensation at 2.8 percent American Medical Group Association News, July 16, 2015

2 FDA approves non-surgical temporary balloon device to treat obesity Full Text FDA Press Announcements, July 29, 2015    Free full text

3 Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's Disease in clinical practice Journal of Gastroenterology and Hepatology, July 15, 2015    Clinical Article

4 Effects of concomitant immunomodulator therapy on efficacy and safety of anti-TNF therapy for Crohn’s disease: A meta-analysis of placebo-controlled trials Clinical Gastroenterology and Hepatology , July 2, 2015    Evidence Based Medicine    Review Article

5 Medical treatment versus surgery for treatment of gastroesophageal reflux disease Techniques in Gastrointestinal Endoscopy , March 6, 2015    Clinical Article

6 Scientists create mini liver segments for drug discovery Wellcome Trust Sanger Institute News, July 15, 2015

7 Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: A 14-year experience The American Journal of Gastroenterology, July 22, 2015    Clinical Article

8 Clinical predictors of thiopurine-related adverse events in Crohn's disease Full Text World Journal of Gastroenterology, July 9, 2015    Free full text    Review Article

9 Prognostic relevance of palliative primary tumor removal in 37,793 metastatic colorectal cancer patients: a population-based, propensity score-adjusted trend analysis Annals of Surgery, June 25, 2015    Clinical Article

10 Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases European Journal of Gastroenterology & Hepatology, July 7, 2015    Clinical Article

11 Vedolizumab: An integrin-receptor antagonist for treatment of Crohn’s disease and ulcerative colitis American Journal of Health-System Pharmacy, July 21, 2015    Clinical Article

12 Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis Alimentary Pharmacology and Therapeutics, July 1, 2015    Clinical Article

13 Effectiveness of anti-TNFα for Crohn's disease: Research in a pediatric learning health system Full Text Pediatrics, July 2, 2014    Free full text    Clinical Article

14 Coffee consumption and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma by sex: The Liver Cancer Pooling Project Cancer Epidemiology, Biomarkers & Prevention, July 9, 2015    Clinical Article

15 Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis Alimentary Pharmacology and Therapeutics, July 6, 2015    Clinical Article

16 Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population The American Journal of Gastroenterology, July 8, 2015    Clinical Article

17 Towards a more accurate estimate of the prevalence of hepatitis C in the United States Hepatology, July 16, 2015    Review Article

18 Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease Alimentary Pharmacology and Therapeutics, July 23, 2015    Clinical Article

19 Management and diagnosis of gallbladder polyps: A systematic review Langenbeck's Archives of Surgery, May 4, 2015    Evidence Based Medicine    Review Article

20 Baclofen for the treatment of muscle cramps in patients with cirrhosis: A new alternative Hepatology, July 20, 2015    Clinical Article

Indexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gutmore

Other Topics in Gastroenterology

Register now to view all our site's content (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from our site and our sponsors
View Samples and Register